A robust population of SARS-CoV-2-reactive CD8+ T cells were identified in the subjects selected for analysis (Figure 3A, Figures S2 and S3), although the abundance of these cells did not significantly differ when stratified by the duration of COVID-19 symptoms (Figure 3B). The gene discussed is CD8A; the disease is COVID-19.